Influenza A virus H1N1 vaccine - iBio/Fraunhofer USA Center for Molecular Biotechnology

Drug Profile

Influenza A virus H1N1 vaccine - iBio/Fraunhofer USA Center for Molecular Biotechnology

Alternative Names: H1N1 vaccine - iBio; H1N1 virus vaccine - iBio; HAC1 vaccine; Influenza A virus H1N1 vaccine - iBio; Swine flu vaccine - iBio

Latest Information Update: 03 May 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator iBio Inc
  • Developer Fraunhofer USA Center for Molecular Biotechnology; iBio Inc
  • Class Influenza A virus H1N1 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Influenza A virus H1N1 subtype

Most Recent Events

  • 03 May 2016 No recent reports on development identified - Phase-I for Influenza-A virus H1N1 subtype (Prevention) in USA (IM)
  • 21 Mar 2012 Final immunogenicity and adverse event data from a phase I trial in Influenza-A virus H1N1 subtype released by Fraunhofer USA Center for Molecular Biotechnology/iBio ,
  • 03 Jun 2011 Interim immunogenicity and safety data from a preclinical trial in Influenza-A virus H1N1 subtype released by Fraunhofer CMB
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top